833 abstracts found.



Results filter

Core outcomes in late phase head and neck cancer clinical trials

Year:

Session type:

A. Waters1, C. Tudur-Smith1, T. Jones1, B. Young1
1University of Liverpool, Liverpool, UK

The COMET (Core Outcome Measures for Effectiveness Trials) Initiative: the importance of core outcome sets for practitioners, patients, policy makers and researchers

Year:

Session type:

P. Williamson1, D. Altman2, J. Blazeby3, M. Clarke4, E. Gargon1
1University of Liverpool, Liverpool, UK, 2University of Oxford, Oxford, UK, 3University of Bristol, Bristol, UK, 4Queen's University Belfast, Belfast, UK

Dietary consumption and diet diversity and risk of developing bladder cancer: Results from the South East China case-control study

Year:

Session type:

Fatima Isa1, Li-Ping Xie2, Zhiquan Hu3, Zhaohui Zhong4, Marjolein Hemelt1, Raoul C Reulen1,8, YC Wong5, Po-Chor Tam6, Kai Yang2, Chao Chai7, Xing Zeng3, Yilan Deng4, Wei-De Zhong7, Maurice Zeegers1,8
1Department of Public Health, Epidemiology and Biostatistics, University of Birmingham, Birmingham, UK, 2Department of Urology, First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China, 3Department of Urology, Tongji Hospital, Tongji Medical University, Wuhan, China, 4Department of Urology,The Second Xiangya Hospital of Central South University, Changsha, China, 5Department of Anatomy, Faculty of Medicine, The University of Hong Kong, Hong Kong, China, 6Department of Surgery, The University of Hong Kong, Hong Kong, China, 7Department of Urology, The 1st Municipal Hospital of Guangzhou, Guangzhou Medical College, Guangzhou, China, 8Department of Complex Genetics, Cluster of Genetics and Cell Biology, Nutrition and Toxicology Research Institute, Maastricht University Hospital, Maastricht, The Netherlands

Data mining of ecological data to confirm exisiting, or generate new hypotheses on environmental risk factors for cancers of the brain and nervous system.

Year:

Session type:

Frank de Vocht1, Kimberly Hannam1, Iain Buchan1
1The University of Manchester, Manchester, UK

Ovarian cancer symptom awareness and anticipated presentation in a population sample

Year:

Session type:

Kate Brain1, Stephanie Smits1, Alice Simon2, Chris Roberts3, Iain Robbe1, John Steward4, Ceri White4, Richard Neal5, Jane Hanson6
1Cardiff University School of Medicine, Cardiff, UK, 2City University, London, UK, 3Welsh Government, Cardiff, UK, 4Welsh Cancer Intelligence and Surveillance Unit, Cardiff, UK, 5Bangor University, Wrexham, UK, 6Cancer National Specialist Advisory Group, Cardiff, UK

Colorectal cancer pathology reporting: a regional audit

Year:

Session type:

Rebecca Birch1,2, Eva Morris1,2, Nicholas West1, Paul Finan1, Phil Quirke1
1University of Leeds, Leeds, UK, 2Northern and Yorkshire Cancer Registry and Information Service, Leeds, UK

UK Lung Cancer Screening Trial: – First 1000 recruits

Year:

Session type:

John Field1, David Baldwin2, Stephen Duffy3, John Holemans4, Martin Ledson4, Nicholas Screaton5, Robert C. Rintoul5, David Hansell7, Anand Devaraj6
1The University of Liverpool, Liverpool, UK, 2Nottingham University Hospital, Nottingham, UK, 3Barts & London University, London, UK, 4Liverpool Heart & Chest Hospital, Liverpool, UK, 5Papworth Hospital, Cambridge, UK, 6St Georges Hospital, London, UK, 7Royal Brompton Hospital, London, UK

Human Papillomavirus 31 integration events and cervical disease progression post-vaccination

Year:

Session type:

Rachel Houghton1, Gavin Wilkinson1, Amanda Tristram1, Sam Hibbitts1
1Cardiff University, Cardiff, UK

The varying influence of socioeconomic deprivation on breast cancer screening uptake in London

Year:

Session type:

Ruth H Jack1, Tony Robson2, Elizabeth A Davies1
1King's College London, London, UK, 2London Quality Assurance Reference Centre, London, UK

Smoking and attitudes towards lung cancer: a review of the literature

Year:

Session type:

Frances Sherratt1,2, Ying Chen1, Russell Hyde1, John Field1, Jude Robinson2
1University of Liverpool Cancer Research Centre, University of Liverpool, Liverpool, Merseyside, UK, 2Dept. of Sociology, Social Policy and Criminology, University of Liverpool, Liverpool, Merseyside, UK

Use of a new biomarker, fractal dimension (Df), in assessing the thromboembolic risk in cancer patients

Year:

Session type:

N. A. Davies1,2, N. K. Harrison3, D. Pudney4, S. N. Stanford1,2, G Mills1,2, G.R. Davies2, M. J. Lawrence1,2, K. Hawkins2, R. H. K. Morris5, P. R. Williams6, P. A. Evans1,2
1Haemostasis Biomedical Research Unit, Abertawe Bro Morgannwg University NHS Trust, Swansea, UK, 2School of Medicine, Swansea University, Swansea, UK, 3Department of Respiratory Medicine, Morriston Hospital, Abertawe Bro Morgannwg University NHS Trust, Swansea, UK, 4Department of Oncology, Singleton Hospital, Abertawe Bro Morgannwg University NHS Trust, Swansea, UK, 5School of Applied Sciences, Cardiff Metropolitan University, Cardiff, UK, 6School of Engineering,Swansea University, Swansea, UK

Identification of single nucleotide polymorphisms associated with lung cancer in a genome-wide association case-control study.

Year:

Session type:

Nicosha De Souza1, Ying Chen1, Michael Marcus1, Olaide Raji1, Russell Hyde1, John K Field1
1University Of Liverpool, Liverpool, UK

Identification of single nucleotide polymorphisms associated with survival of lung cancer patients using logistic regression for grouped survival data.

Year:

Session type:

Nicosha De Souza1, Olaide Raji1, Martin Ledson2, Richard Page2, Russell Hyde1, John K Field1
1University Of Liverpool, Liverpool, UK, 2Liverpool Heart & Chest Hospital, Liverpool, UK

Travel time and access to healthcare for teenagers and young adults with cancer

Year:

Session type:

Rebecca Birch1, Richard Feltbower1, Eva Morris2,3, Robert West4, Dan Stark5, Ian Lewis6, Sue Morgan5
1Paediatric Epidemiology Group, University of Leeds, Leeds, UK, 2Cancer Epidemiology Group, University of Leeds, Leeds, UK, 3Northern and Yorkshire Cancer Registry and Information Service, Leeds, UK, 4Leeds Institute of Health Sciences, Leeds, UK, 5Institute of Oncology, St James’s University Hospital, Leeds, UK, 6Alder Hey Children’s Hospital, Liverpool, UK

Alcohol consumption, body mass index and breast cancer prognosis: results from the SEARCH study

Year:

Session type:

Alaa Ali1,2, Mitul Shah3, Douglas Easton3, Paul Pharoah1,3
1Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK, 2South Egypt Cancer Institute, Assiut, Egypt, 3Department of Oncology, Cambridge, UK

Evidence for an infectious aetiology associated with cancer amongst 15-24 year olds in England, 1996-2005

Year:

Session type:

Marlous van Laar1, Sally Kinsey2, Sue Picton2, Richard Feltbower1
1University of Leeds, Leeds, UK, 2Leeds Teaching Hospitals NHS Trust, Leeds, UK

Hard to reach groups in lung screening: Recommendations for the UK Lung Cancer Screening (UKLS) trial

Year:

Session type:

Kate Lifford1, Jana Witt1, Stephen Duffy2, David Weller3, Chris Hands4, David Baldwin5, John Field4, Kate Brain1
1Cardiff University, Cardiff, UK, 2Queen Mary University of London, London, UK, 3University of Edinburgh, Edinburgh, UK, 4University of Liverpool, Liverpool, UK, 5Nottingham University, Nottingham, UK

Recent trends in resection rates among non-small cell lung cancer patients in England 

Year:

Session type:

Sharma P. Riaz1, Karen M. Linklater1, Richard Page2, Michael D. Peake3,4, Henrik Møller1, Margreet Lüchtenborg1
1King’s College London, Thames Cancer Registry, London, UK, 2Department of Thoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, UK, 3National Cancer Intelligence Network, London, UK, 4Department of Respiratory Medicine, Glenfield Hospital, Leicester, UK

Association of non-malignant respiratory disease with predicted lung cancer risk

Year:

Session type:

Stephen W. Duffy1, Ghasem Yadegarfar2, David Baldwin3, John Holemans4, Martin Ledson4, Nicholas Screaton5, Robert Rintoul5, Anand Devaraj6, David M. Hansell7, John K. Field2
1Queen Mary, University of London, London, UK, 2University of Liverpool, Liverpool, UK, 3Nottingham University Hospital, Nottingham, UK, 4Liverpool Heart and Chest Hospital, Liverpool, UK, 5Papworth Hospital, Cambridgeshire, UK, 6St George's Hospital, London, UK, 7Royal Brompton Hospital, London, UK

Uterine Artery Pulsatility Index (UAPI) Improves Prediction of Methotrexate Resistance (MTX-R) Risk in Patients with Gestational Trophoblastic Neoplasia (GTN) and FIGO score 5-6

Year:

Session type:

Ailsa Sita-Lumsden1,2, Hanine Medani1, Victoria Harding1, Rosemary Fisher1,2, Dee Short1, Neil Sebire1,2, Richard Harvey1, Philip Savage1, Adrian Lim1, Michael Seckl1, Roshan Agarwal1
1Imperial NHS Trust, London, UK, 2Imperial College London, London, UK

Sunitinib therapy for metastatic renal cell carcinoma – the Mersey experience

Year:

Session type:

Anna Mullard1, Simon Purcell1, Judith Carser1, Richard Griffiths1
1Clatterbridge Cancer Centre, Merseyside, UK

Evaluation of a cancer of unknown primary (CUP) service – the first two years

Year:

Session type:

T. Tillett1, A. Kuchel1, L. Medley1
1Royal United Hospital, Bath, UK

Patient-reported outcomes of colorectal cancer surgery: A systematic review of outcome measures

Year:

Session type:

R. Whistance1, R. Forsythe2, J. Jones3, G. Smith3, A. Pullyblank4, A. McNair1, S. Brookes1, K. Avery1, J. Blazeby1
1Academic Unit of Surgical Research, School of Social and Community Medicine, University of Bristol, Bristol, UK, 2Division of Surgery Head and Neck, University Hospitals Bristol NHS Foundation Trust, Bristol, UK, 3Colorectal Cancer Patient Representative, North Bristol NHS Trust, Bristol, UK, 4Department of General Surgery, North Bristol NHS Trust, Bristol, UK

The effect of comorbidity on stage-specific survival in resected non-small celllung cancer patients

Year:

Session type:

M. Lüchtenborg1,2, E. Jakobsen3,4, M. Krasnik5, K. Linklater1,2, A. Mellemgaard5, H. Møller1,2
1King's College London, London, UK, 2Thames Cancer Registry, London, UK, 3The Danish Lung Cancer Registry, Denmark, Denmark, 4Odense University Hospital 'Rigshospitalet', Odense, Denmark, 5Copenhagen University Hospital at Herlev, Herlev, Denmark

Second primary cancer risk after breast,colorectal and prostate cancers: Results from long-term follow-up of cancer registry patients in Scotland

Year:

Session type:

A. Coyte1, D. Morrisson2,3
1University of Glasgow Medical School, Glasgow, UK, 2West of Scotland Cancer Surveillance Unit, Scotland, UK, 3University of Glasgow, Glasgow, UK

Using hospital in-patient data to assess comorbidity in cancer patients: Is it fit for purpose?

Year:

Session type:

M. De Camargo Cancela1, L. Sharp1, M. Kelly1, H. Comber1
1National Cancer Registry Ireland, Cork, Ireland

Measuring co-morbidity for sarcoma patients

Year:

Session type:

M. Francis1, G. Lawrence1
1West Midlands Cancer Intelligence Unit, Birmingham, UK

Geographical variation of cancer in Ireland 1995-2007

Year:

Session type:

A. Gavin1, H. Comber2, S. Deady2, N. McCluskey2, D. Donnelly1, A. Hegarty3, A-E. Carsin4
1Northern Ireland Cancer Registry, Belfast, UK, 2National Cancer Registry Ireland, Cork, Ireland, 3University of Limerick, Limerick, Ireland, CREALCentre for Research in Environmental Epidemiology

Incidence and survival of patients with soft tissue sarcomas – Analyses by histological subtype

Year:

Session type:

M. Francis1, G. Lawrence1, R. Grimer2, N. Athanasou3, J. Fairbairn4, S. Vernon5
1West Midlands Cancer Intelligence Unit, Birmingham, UK, 2Royal Orthopaedic Hospital NHS Foundation Trust, Birmingham, UK, 3Nuffield Department of Orthopaedics, Rheumatology & Musculoskeletal Sciences, Oxford, UK, 4Nottingham University Hospitals NHS Trust, Nottingham, UK, 5Eastern Cancer Registration & Information Centre, Cambridge, UK

Trends in incidence of primary liver cancer subtypes before and after the implementation of ICD-10, England 1990-2008

Year:

Session type:

J. Konfortion1, V. Coupland1, H. Kocher2, W. Allum3, D. Berry4, R. Jack1
1King's College London, London, UK, 2Barts Cancer Institute, London, UK, 3Royal Marsden Hospital, London, UK, 4University Hospital Wales, Cardiff, UK

Outcomes in Pregnancy Associated Breast Cancer: A Single Centre Experience

Year:

Session type:

Sreedevi Kumar1, Louise Murray2, Zakeea Sher2, Mark Teo1, Ada Keding1, Joji Joseph1
1St James's Institute of Oncology, Leeds, UK, 2University of Leeds, Leeds, UK

On-line portal for the validation of BCCOM data: results from year one

Year:

Session type:

C. Lagord1, B. Shand2, L. Madras-Purushothaman1, O. Kearins1, J. Rashbass2, G. Rashbass1, A. Hartnett1
1West Midlands Cancer Intelligence Unit, Birmingham, UK, 2Eastern Cancer Registration & Information Centre, Cambridge, UK

A feasibility randomised controlled trial of dietary interventions for prostate cancer prevention: ProDiet

Year:

Session type:

J Athene Lane1, David Gillatt2, Jeff Holly1, Richard Martin1, Alan Crozier3, Marie Cantwell4, Freddie Hamdy5, David Neal6, Jenny Donovan1, Chris Metcalfe1
1University of Bristol, Bristol, UK, 2North Bristol Trust, Bristol, UK, 3University of Glasgow, Glasgow, UK, 4Queen's University of Belfast, Belfast, UK, 5University of Oxford, Oxford, UK, 6Addenbokes's Hospital, Cambridge, UK